Life ScienceCompany
CNX Therapeutics Ownership
Who owns CNX Therapeutics?
CNX Therapeutics is owned by Inflexion. It was acquired on August 19, 2021.
Is CNX Therapeutics PE-backed?
Yes. CNX Therapeutics is owned by private equity investor Inflexion.
CNX Therapeutics Business Overview
Where is CNX Therapeutics headquartered?
CNX Therapeutics is headquartered in London, United Kingdom.
What sector is CNX Therapeutics in?
CNX Therapeutics is a life science company.
Life Science M&A Summary in 2021
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.
Join Mergr to view all 397 acquisitions of life science companies in 2021, including 46 acquisitions by private equity firms, and 351 by strategics.